Mark Morris
Reader in Molecular Oncology
Biology
University of Wolverhampton
United Kingdom
Biography
Dr Mark Morris leads a research group within the Research Institute In Healthcare Science (RHIS) investigating the molecular biology and genetics of cancer development. Mark gained his PhD in 2001 following a period of research (at the University of Wales College of Medicine) into the regulation of proliferative life-span barriers in human tumours. Prior to joining the University of Wolverhampton, in 2010, Mark investigated the molecular basis of cancer and developmental diseases with a particulate interest in epigenetic gene dysregulation as a mechanism that drives tumour formation. This research was carried out at the Department of Medical Genetics, University of Birmingham, where he currently holds the post of Honorary Lecturer in Molecular Oncology. His teaching includes general biochemistry, cell biology, and molecular genetics, particularly related to human disease.
Research Interest
The role of epigenetic gene dysregulation in the process of tumour formation and metastasis. The role epigenetics (in particular DNA methylation and microRNAs) play in the development of childhood cancers of the brain and the kidney. RNA-processing in tumour development. The identification of new therapeutics against cancer.
